Newell Brands Inc. (NWL) stock
NWLNasdaqPlastics Products, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 9/3011% below fair value
$5.18+0.10 (+1.97%)
Close on Oct 30, 2026Market cap $2.21BP/E –Yield 5.41%
Earnings
Newell Brands's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 5, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$1.90B
+5.6% on a year earlier
Normalized diluted EPS, Q3 FY2026
$0.20
$0.17 a year earlier
Latest guidance
Issued
Oct 30, 2026 · 9 items
Quarterly results
Revenue and earnings per share from each of Newell Brands's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 5, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 30, 2026before the open | $1.90B | +5.6% | -$0.19 | $0.20 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 31, 2026before the open | $2.00B | +5.3% | $0.25 | $0.42 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 1, 2026before the open | $1.50B | -6.3% | -$0.08 | -$0.05 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 6, 2026before the open | $1.90B | 0.0% | -$0.75 | $0.18 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 31, 2025before the open | $1.80B | -5.3% | $0.05 | $0.17 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 1, 2025before the open | $1.90B | -5.0% | $0.11 | $0.24 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 30, 2025before the open | $1.60B | -5.9% | -$0.09 | -$0.01 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 7, 2025before the open | $1.90B | -9.5% | -$0.13 | $0.16 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 25, 2024before the open | $1.90B | -5.0% | -$0.48 | $0.16 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 26, 2024before the open | $2.00B | -9.1% | $0.11 | $0.36 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 26, 2024before the open | $1.70B | -5.6% | -$0.02 | $0.00 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 9, 2024before the open | $2.10B | -8.7% | -$0.21 | $0.22 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 27, 2023before the open | $2.00B | -13.0% | -$0.53 | $0.39 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 28, 2023before the open | $2.20B | -12.0% | $0.04 | $0.24 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 28, 2023before the open | $1.80B | -25.0% | -$0.25 | -$0.06 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 10, 2023before the open | $2.30B | -17.9% | -$0.60 | $0.16 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 28, 2022before the open | $2.30B | -17.9% | $0.07 | $0.53 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 29, 2022before the open | $2.50B | – | $0.49 | $0.57 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 29, 2022before the open | $2.40B | – | $0.55 | $0.36 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 11, 2022before the open | $2.80B | – | $0.22 | $0.42 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 29, 2021before the open | $2.80B | – | $0.44 | $0.54 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 30, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 30, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 12, 2021before the open | – | – | – | – | Release |
| Q3 FY2020ended Sep 30, 2020 | Oct 30, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Newell Brands's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Core Salesnon-GAAP | Q4 FY2026 | +1% – +3% | – | New | Oct 30, 2026 |
| Net SalesGAAP | Q4 FY2026 | +1% – +3% | – | New | Oct 30, 2026 |
| Normalized Operating Marginnon-GAAP | Q4 FY2026 | 8.4% – 9% | – | New | Oct 30, 2026 |
| Normalized EPSnon-GAAP | Q4 FY2026 | $0.17 – $0.19 | – | New | Oct 30, 2026 |
| Core Salesnon-GAAP | FY2026 | +1% – +2% | – | New | Oct 30, 2026 |
| Net SalesGAAP | FY2026 | +2% – +3% | – | New | Oct 30, 2026 |
| Net SalesGAAP | FY2026 | +1% – +2% | -1% – +1% | Raised | Jul 31, 2026 |
| Core Salesnon-GAAP | FY2026 | -1% – +1% | – | New | May 1, 2026 |
| Normalized Operating Marginnon-GAAP | FY2026 | 10% – 10.4% | – | New | Oct 30, 2026 |
| Normalized Operating Marginnon-GAAP | FY2026 | 10% – 10.4% | 8.6% – 9.2% | Raised | Jul 31, 2026 |
| Normalized EPSnon-GAAP | FY2026 | $0.74 – $0.76 | – | New | Oct 30, 2026 |
| Normalized EPSnon-GAAP | FY2026 | $0.73 – $0.77 | $0.56 – $0.60 | Raised | Jul 31, 2026 |
| Core Salesnon-GAAP | FY2026 | -2% – 0% | – | New | Feb 6, 2026 |
| operating cash flowGAAP | FY2026 | $150.00M | – | New | Oct 30, 2026 |
| operating cash flow | FY2026 | $400.00M | $350.00M – $400.00M | Raised | Jul 31, 2026 |
Guidance vs results
The last range Newell Brands gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | Normalized EPS | $0.18 – $0.20 | $0.20 | Within range |
| Q3 FY2026 | Revenue growth | +2% – +3% | +5.56% | Above range |
| Q2 FY2026 | Normalized EPS | $0.16 – $0.19 | $0.42 | Above range |
| Q1 FY2026 | Normalized EPS | -$0.12 – -$0.08 | -$0.05 | Above range |
| Q1 FY2026 | Revenue growth | -5% – -3% | -6.25% | Below range |
| Q4 FY2025 | Normalized EPS | $0.16 – $0.20 | $0.18 | Within range |
| Q4 FY2025 | Revenue growth | -4% – -1% | 0% | Above range |
| Q3 FY2025 | Normalized EPS | $0.16 – $0.19 | $0.17 | Within range |
| Q3 FY2025 | Revenue growth | -4% – -2% | -5.26% | Below range |
| Q2 FY2025 | Normalized EPS | $0.21 – $0.24 | $0.24 | Within range |
| Q2 FY2025 | Revenue growth | -5% – -3% | -5% | Within range |
| Q1 FY2025 | Normalized EPS | -$0.09 – -$0.06 | -$0.01 | Above range |
| Q1 FY2025 | Revenue growth | -8% – -5% | -5.88% | Within range |
| Q4 FY2024 | Normalized EPS | $0.11 – $0.14 | $0.16 | Above range |
| Q4 FY2024 | Revenue growth | -7% – -4% | -9.52% | Below range |
| Q3 FY2024 | Normalized EPS | $0.14 – $0.17 | $0.16 | Within range |
| Q3 FY2024 | Revenue growth | -6% – -4% | -5% | Within range |
| Q2 FY2024 | Normalized EPS | $0.18 – $0.21 | $0.36 | Above range |
| Q2 FY2024 | Revenue growth | -9% – -7% | -9.09% | Below range |
| Q1 FY2024 | Normalized EPS | -$0.09 – -$0.05 | $0.00 | Above range |
| Q1 FY2024 | Revenue growth | -10% – -8% | -5.56% | Above range |
| Q4 FY2023 | Normalized EPS | $0.15 – $0.20 | $0.22 | Above range |
| Q4 FY2023 | Revenue | $1.96B – $2.03B | $2.10B | Above range |
| Q3 FY2023 | Normalized EPS | $0.20 – $0.24 | $0.39 | Above range |
| Q3 FY2023 | Revenue | $2.11B – $2.16B | $2.00B | Below range |
| Q2 FY2023 | Normalized EPS | $0.10 – $0.18 | $0.24 | Above range |
| Q2 FY2023 | Revenue | $2.13B – $2.24B | $2.20B | Within range |
| Q1 FY2023 | Normalized EPS | -$0.06 – -$0.03 | -$0.06 | Within range |
| Q1 FY2023 | Revenue | $1.79B – $1.84B | $1.80B | Within range |
| Q4 FY2022 | Normalized EPS | $0.09 – $0.14 | $0.16 | Above range |
| Q4 FY2022 | Revenue | $2.18B – $2.26B | $2.30B | Above range |
| Q4 FY2022 | Revenue growth | -12% – -9% | -17.86% | Below range |
| Q3 FY2022 | Normalized EPS | $0.50 – $0.54 | $0.53 | Within range |
| Q3 FY2022 | Revenue | $2.39B – $2.50B | $2.30B | Below range |
| Q2 FY2022 | Normalized EPS | $0.45 – $0.48 | $0.57 | Above range |
| Q2 FY2022 | Revenue | $2.52B – $2.57B | $2.50B | Below range |
| Q1 FY2022 | Normalized EPS | $0.26 – $0.28 | $0.36 | Above range |
| Q1 FY2022 | Revenue | $2.25B – $2.30B | $2.40B | Above range |
Guidance history
Every forecast Newell Brands put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 30, 2026 | Normalized EPS | FY2026 | $0.74 – $0.76 | New |
| Oct 30, 2026 | Normalized EPS | Q4 FY2026 | $0.17 – $0.19 | New |
| Oct 30, 2026 | Normalized Operating Margin | Q4 FY2026 | 8.4% – 9% | New |
| Oct 30, 2026 | Normalized Operating Margin | FY2026 | 10% – 10.4% | New |
| Oct 30, 2026 | operating cash flow | FY2026 | $150.00M | New |
| Oct 30, 2026 | Net Sales | FY2026 | +2% – +3% | New |
| Oct 30, 2026 | Core Sales | Q4 FY2026 | +1% – +3% | New |
| Oct 30, 2026 | Core Sales | FY2026 | +1% – +2% | New |
| Oct 30, 2026 | Net Sales | Q4 FY2026 | +1% – +3% | New |
| Jul 31, 2026 | Normalized EPS | FY2026 | $0.73 – $0.77 | Raised |
| Jul 31, 2026 | Normalized EPS | Q3 FY2026 | $0.18 – $0.20 | New |
| Jul 31, 2026 | Normalized Operating Margin | FY2026 | 10% – 10.4% | Raised |
| Jul 31, 2026 | Normalized Operating Margin | Q3 FY2026 | 9.5% – 10.2% | New |
| Jul 31, 2026 | operating cash flow | FY2026 | $400.00M | Raised |
| Jul 31, 2026 | Core Sales | Q3 FY2026 | +2% – +3% | New |
| Jul 31, 2026 | Net Sales | FY2026 | +1% – +2% | Raised |
| Jul 31, 2026 | Net Sales | Q3 FY2026 | +2% – +3% | New |
| May 1, 2026 | Core Sales | FY2026 | -1% – +1% | New |
| May 1, 2026 | Normalized EPS | FY2026 | $0.56 – $0.60 | Raised |
| May 1, 2026 | Normalized EPS | Q2 FY2026 | $0.16 – $0.19 | New |
| May 1, 2026 | Normalized Operating Margin | FY2026 | 8.6% – 9.2% | Reaffirmed |
| May 1, 2026 | Normalized Operating Margin | Q2 FY2026 | 9.6% – 10.2% | New |
| May 1, 2026 | operating cash flow | FY2026 | $350.00M – $400.00M | Reaffirmed |
| Feb 6, 2026 | Normalized EPS | FY2026 | $0.54 – $0.60 | New |
| Feb 6, 2026 | Normalized EPS | Q1 FY2026 | -$0.12 – -$0.08 | New |
| Feb 6, 2026 | Normalized Operating Margin | FY2026 | 8.6% – 9.2% | New |
| Feb 6, 2026 | Normalized Operating Margin | Q1 FY2026 | 2.5% – 3.5% | New |
| Feb 6, 2026 | Core Sales | FY2026 | -2% – 0% | New |
| Feb 6, 2026 | operating cash flow | FY2026 | $350.00M – $400.00M | New |
| Feb 6, 2026 | Core Sales | Q1 FY2026 | -7% – -5% | New |
| Feb 6, 2026 | Net Sales | FY2026 | -1% – +1% | New |
| Feb 6, 2026 | Net Sales | Q1 FY2026 | -5% – -3% | New |
| Oct 31, 2025 | Normalized EPS | Q4 FY2025 | $0.16 – $0.20 | New |
| Oct 31, 2025 | Normalized Operating Margin | Q4 FY2025 | 9% – 9.5% | New |
| Oct 31, 2025 | operating cash flow | FY2025 | $250.00M – $300.00M | New |
| Oct 31, 2025 | Net Sales | Q4 FY2025 | -4% – -1% | New |
| Oct 31, 2025 | Core Sales | Q4 FY2025 | -5% – -3% | New |
| Aug 1, 2025 | Normalized EPS | Q3 FY2025 | $0.16 – $0.19 | New |
| Aug 1, 2025 | Normalized EPS | FY2025 | $0.66 – $0.70 | Lowered |
| Aug 1, 2025 | Normalized Operating Margin | Q3 FY2025 | 9.1% – 9.5% | New |
| Aug 1, 2025 | Normalized Operating Margin | FY2025 | 9% – 9.5% | Reaffirmed |
| Aug 1, 2025 | operating cash flow | FY2025 | $400.00M – $450.00M | Lowered |
| Aug 1, 2025 | Net Sales | Q3 FY2025 | -4% – -2% | New |
| Aug 1, 2025 | Core Sales | Q3 FY2025 | -4% – -2% | New |
| Aug 1, 2025 | Net Sales | FY2025 | -3% – -2% | Raised |
| Aug 1, 2025 | Core Sales | FY2025 | -3% – -2% | Lowered |
| Apr 30, 2025 | Normalized EPS | Q2 FY2025 | $0.21 – $0.24 | New |
| Apr 30, 2025 | Normalized EPS | FY2025 | $0.70 – $0.76 | Reaffirmed |
| Apr 30, 2025 | Normalized Operating Margin | Q2 FY2025 | 10.4% – 10.8% | New |
| Apr 30, 2025 | Normalized Operating Margin | FY2025 | 9% – 9.5% | Reaffirmed |
| Apr 30, 2025 | operating cash flow | FY2025 | $400.00M – $500.00M | New |
| Apr 30, 2025 | Net Sales | Q2 FY2025 | -5% – -3% | New |
| Apr 30, 2025 | Core Sales | Q2 FY2025 | -5% – -3% | New |
| Apr 30, 2025 | Net Sales | FY2025 | -4% – -2% | Reaffirmed |
| Apr 30, 2025 | Core Sales | FY2025 | -3% – -1% | New |
| Feb 7, 2025 | Core Sales | Q1 FY2025 | -4% – -2% | New |
| Feb 7, 2025 | Core Sales | FY2025 | -2% – +1% | New |
| Feb 7, 2025 | Normalized EPS | Q1 FY2025 | -$0.09 – -$0.06 | New |
| Feb 7, 2025 | Normalized EPS | FY2025 | $0.70 – $0.76 | New |
| Feb 7, 2025 | Normalized Operating Margin | Q1 FY2025 | 2% – 4% | New |
| Feb 7, 2025 | Normalized Operating Margin | FY2025 | 9% – 9.5% | New |
| Feb 7, 2025 | operating cash flow | FY2025 | $450.00M – $500.00M | New |
| Feb 7, 2025 | Net Sales | Q1 FY2025 | -8% – -5% | New |
| Feb 7, 2025 | Net Sales | FY2025 | -4% – -2% | New |
| Oct 25, 2024 | Normalized EPS | Q4 FY2024 | $0.11 – $0.14 | New |
| Oct 25, 2024 | Normalized EPS | FY2024 | $0.63 – $0.66 | Raised |
| Oct 25, 2024 | Normalized Operating Margin | Q4 FY2024 | 7% – 7.7% | New |
| Oct 25, 2024 | Normalized Operating Margin | FY2024 | 8.1% – 8.3% | Raised |
| Oct 25, 2024 | Core Sales | Q4 FY2024 | -5% – -2% | New |
| Oct 25, 2024 | Core Sales | FY2024 | -4% – -3% | New |
| Oct 25, 2024 | operating cash flow | FY2024 | $500.00M – $600.00M | Raised |
| Oct 25, 2024 | Net Sales | FY2024 | -7% – -6% | Reaffirmed |
| Oct 25, 2024 | Net Sales | Q4 FY2024 | -7% – -4% | New |
| Jul 26, 2024 | Normalized EPS | Q3 FY2024 | $0.14 – $0.17 | New |
| Jul 26, 2024 | Normalized EPS | FY2024 | $0.60 – $0.65 | Raised |
| Jul 26, 2024 | Normalized Operating Margin | Q3 FY2024 | 8.3% – 8.8% | New |
| Jul 26, 2024 | Normalized Operating Margin | FY2024 | 8% – 8.2% | Raised |
| Jul 26, 2024 | operating cash flow | FY2024 | $450.00M – $550.00M | New |
| Jul 26, 2024 | Net Sales | Q3 FY2024 | -6% – -4% | New |
| Jul 26, 2024 | Net Sales | FY2024 | -7% – -6% | Narrowed |
| Jul 26, 2024 | Core Sales | FY2024 | -4% – -3% | Raised |
| Apr 26, 2024 | Normalized EPS | Q2 FY2024 | $0.18 – $0.21 | New |
| Apr 26, 2024 | Normalized EPS | FY2024 | $0.52 – $0.62 | Reaffirmed |
| Apr 26, 2024 | Normalized Operating Margin | Q2 FY2024 | 9.1% – 9.6% | New |
| Apr 26, 2024 | Normalized Operating Margin | FY2024 | 7.8% – 8.2% | Reaffirmed |
| Apr 26, 2024 | operating cash flow | FY2024 | $400.00M – $500.00M | Reaffirmed |
| Apr 26, 2024 | Net Sales | Q2 FY2024 | -9% – -7% | New |
| Apr 26, 2024 | Core Sales | Q2 FY2024 | -6% – -4% | New |
| Apr 26, 2024 | Net Sales | FY2024 | -8% – -5% | Reaffirmed |
| Apr 26, 2024 | Core Sales | FY2024 | -6% – -3% | New |
| Feb 9, 2024 | Core Sales | Q1 FY2024 | -8% – -6% | New |
| Feb 9, 2024 | Core Sales | FY2024 | -6% – -3% | New |
| Feb 9, 2024 | Normalized EPS | Q1 FY2024 | -$0.09 – -$0.05 | New |
| Feb 9, 2024 | Normalized EPS | FY2024 | $0.52 – $0.62 | New |
| Feb 9, 2024 | Normalized Operating Margin | Q1 FY2024 | 2.4% – 3.2% | New |
| Feb 9, 2024 | Normalized Operating Margin | FY2024 | 7.8% – 8.2% | New |
| Feb 9, 2024 | operating cash flow | FY2024 | $400.00M – $500.00M | New |
| Feb 9, 2024 | Net Sales | Q1 FY2024 | -10% – -8% | New |
| Feb 9, 2024 | Net Sales | FY2024 | -8% – -5% | New |
| Oct 27, 2023 | Core Sales | Q4 FY2023 | -14% – -11% | New |
| Oct 27, 2023 | Core Sales | FY2023 | -13% | Lowered |
| Oct 27, 2023 | Normalized EPS | Q4 FY2023 | $0.15 – $0.20 | New |
| Oct 27, 2023 | normalized earnings per share | FY2023 | $0.72 – $0.77 | Lowered |
| Oct 27, 2023 | Normalized Operating Margin | Q4 FY2023 | 7.8% – 8.8% | New |
| Oct 27, 2023 | Normalized Operating Margin | FY2023 | 7% – 7.3% | Lowered |
| Oct 27, 2023 | operating cash flow | FY2023 | $800.00M – $900.00M | Raised |
| Oct 27, 2023 | Net Sales | Q4 FY2023 | $1.96B – $2.03B | New |
| Oct 27, 2023 | net sales | FY2023 | $8.02B – $8.09B | Lowered |
| Jul 28, 2023 | Core Sales | Q3 FY2023 | -7% – -5% | New |
| Jul 28, 2023 | Core Sales | FY2023 | -12% – -10% | Lowered |
| Jul 28, 2023 | Normalized EPS | Q3 FY2023 | $0.20 – $0.24 | New |
| Jul 28, 2023 | normalized earnings per share | FY2023 | $0.80 – $0.90 | Lowered |
| Jul 28, 2023 | Normalized Operating Margin | Q3 FY2023 | 8.5% – 9.4% | New |
| Jul 28, 2023 | Normalized Operating Margin | FY2023 | 7.8% – 8.2% | Lowered |
| Jul 28, 2023 | operating cash flow | FY2023 | $700.00M – $900.00M | Reaffirmed |
| Jul 28, 2023 | Net Sales | Q3 FY2023 | $2.11B – $2.16B | New |
| Jul 28, 2023 | net sales | FY2023 | $8.20B – $8.34B | Lowered |
| Apr 28, 2023 | Core Sales | Q2 FY2023 | -14% – -10% | New |
| Apr 28, 2023 | Core Sales | FY2023 | -8% – -6% | Reaffirmed |
| Apr 28, 2023 | Normalized EPS | Q2 FY2023 | $0.10 – $0.18 | New |
| Apr 28, 2023 | Normalized EPS | FY2023 | $0.95 – $1.08 | Reaffirmed |
| Apr 28, 2023 | Normalized Operating Margin | Q2 FY2023 | 6.5% – 8% | New |
| Apr 28, 2023 | Normalized Operating Margin | FY2023 | 9.6% – 10.1% | Reaffirmed |
| Apr 28, 2023 | operating cash flow | FY2023 | $700.00M – $900.00M | Reaffirmed |
| Apr 28, 2023 | Net Sales | Q2 FY2023 | $2.13B – $2.24B | New |
| Apr 28, 2023 | Net Sales | FY2023 | $8.40B – $8.60B | Reaffirmed |
| Feb 10, 2023 | Core Sales | Q1 FY2023 | -18% – -16% | New |
| Feb 10, 2023 | Core Sales | FY2023 | -8% – -6% | New |
| Feb 10, 2023 | Normalized EPS | Q1 FY2023 | -$0.06 – -$0.03 | New |
| Feb 10, 2023 | Normalized EPS | FY2023 | $0.95 – $1.08 | New |
| Feb 10, 2023 | Normalized Operating Margin | Q1 FY2023 | 3% – 3.5% | New |
| Feb 10, 2023 | Normalized Operating Margin | FY2023 | 9.6% – 10.1% | New |
| Feb 10, 2023 | operating cash flow | FY2023 | $700.00M – $900.00M | New |
| Feb 10, 2023 | Net Sales | Q1 FY2023 | $1.79B – $1.84B | New |
| Feb 10, 2023 | Net Sales | FY2023 | $8.40B – $8.60B | New |
| Oct 28, 2022 | Normalized EPS | Q4 FY2022 | $0.09 – $0.14 | New |
| Oct 28, 2022 | Normalized EPS | FY2022 | $1.56 – $1.61 | Lowered |
| Oct 28, 2022 | Normalized Operating Margin | Q4 FY2022 | 5.1% – 6.5% | New |
| Oct 28, 2022 | Normalized Operating Margin | FY2022 | 10% – 10.3% | Lowered |
| Oct 28, 2022 | Core Sales | Q4 FY2022 | -12% – -9% | New |
| Oct 28, 2022 | Net Sales | Q4 FY2022 | $2.18B – $2.26B | New |
| Oct 28, 2022 | Core Sales | FY2022 | -4% – -3% | New |
| Oct 28, 2022 | Net Sales | FY2022 | $9.35B – $9.43B | Lowered |
| Jul 29, 2022 | Core Sales | Q3 FY2022 | -5% – -1% | New |
| Jul 29, 2022 | Normalized EPS | Q3 FY2022 | $0.50 – $0.54 | New |
| Jul 29, 2022 | normalized earnings per share | FY2022 | $1.79 – $1.86 | Lowered |
| Jul 29, 2022 | Normalized Operating Margin | Q3 FY2022 | 10.7% – 11% | New |
| Jul 29, 2022 | Normalized Operating Margin | FY2022 | 11.2% – 11.4% | Lowered |
| Jul 29, 2022 | operating cash flow | FY2022 | $700.00M – $800.00M | Lowered |
| Jul 29, 2022 | Net Sales | Q3 FY2022 | $2.39B – $2.50B | New |
| Jul 29, 2022 | Net Sales | FY2022 | $9.76B – $9.98B | Lowered |
| Apr 29, 2022 | Core sales change | Q2 FY2022 | +1% – +3% | New |
| Apr 29, 2022 | Core sales change | FY2022 | 0% – +2% | New |
| Apr 29, 2022 | Normalized EPS | Q2 FY2022 | $0.45 – $0.48 | New |
| Apr 29, 2022 | Normalized EPS | FY2022 | $1.85 – $1.93 | Reaffirmed |
| Apr 29, 2022 | Normalized Operating Margin | Q2 FY2022 | 11.7% – 12.1% | New |
| Apr 29, 2022 | Normalized Operating Margin | FY2022 | 11.5% – 11.8% | Reaffirmed |
| Apr 29, 2022 | operating cash flow | FY2022 | $800.00M – $850.00M | Reaffirmed |
| Apr 29, 2022 | Net Sales | Q2 FY2022 | $2.52B – $2.57B | New |
| Apr 29, 2022 | Net Sales | FY2022 | $9.93B – $10.13B | Reaffirmed |
| Feb 11, 2022 | Core Sales | Q1 FY2022 | +2% – +4% | New |
| Feb 11, 2022 | Normalized EPS | Q1 FY2022 | $0.26 – $0.28 | New |
| Feb 11, 2022 | Normalized EPS | FY2022 | $1.85 – $1.93 | New |
| Feb 11, 2022 | Normalized Operating Margin | Q1 FY2022 | 8.9% – 9.3% | New |
| Feb 11, 2022 | Normalized Operating Margin | FY2022 | 11.5% – 11.8% | New |
| Feb 11, 2022 | operating cash flow | FY2022 | $800.00M – $850.00M | New |
| Feb 11, 2022 | Net Sales | Q1 FY2022 | $2.25B – $2.30B | New |
| Feb 11, 2022 | Net Sales | FY2022 | $9.93B – $10.13B | New |
| Oct 29, 2021 | core sales growth | FY2021 | +10% – +11% | New |
| Oct 29, 2021 | normalized earnings per share | FY2021 | $1.69 – $1.73 | New |
| Oct 29, 2021 | Net Sales | FY2021 | $10.38B – $10.46B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Newell Brands filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- News
- Results
- Results
- Results
- Update
- Results
- Results
- News
- News
- Results
- Results
- Results
- Results